Waning immunity and re-emergence of measles and mumps in the vaccine era

被引:29
|
作者
Yang, Luojun [1 ,2 ]
Grenfell, Bryan T. [1 ,3 ]
Mina, Michael J. [2 ,4 ,5 ]
机构
[1] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Dept Immunol & Infect Dis, Ctr Communicable Dis Dynam, Boston, MA 02115 USA
[3] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA
[4] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
LIVED PLASMA-CELLS; LONG-TERM; HUMORAL IMMUNITY; UNITED-STATES; SCHOOL POPULATION; LATE CONVALESCENT; VIRUS-ANTIBODIES; SERUM ANTIBODY; HERPES-ZOSTER; RISK-FACTORS;
D O I
10.1016/j.coviro.2020.05.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vaccine-preventable diseases (VPD) including measles and mumps have been re-emerging in countries with sustained high vaccine coverage. For mumps, waning immunity has been recognized as a major contributor to recent outbreaks. Although unvaccinated individuals account for most cases in recent measles outbreaks, the role of immune waning remains unclear. Accumulating serological and epidemiological evidence suggests that natural immunity induced by infection may be more durable compared to vaccine-induced immunity. As the proportion of population immunity via vaccination gradually increases and boosting through natural exposures becomes rare, risk of outbreaks may increase. Mechanistic insights into the coupled immuno-epidemiological dynamics of waning and boosting will be important to understand optimal vaccination strategies to combat VPD re-emergence and achieve eradication.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 50 条
  • [21] The re-emergence of natural products for drug discovery in the genomics era
    Harvey, Alan L.
    Edrada-Ebel, RuAngelie
    Quinn, Ronald J.
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (02) : 111 - 129
  • [22] The re-emergence of natural products for drug discovery in the genomics era
    Alan L. Harvey
    RuAngelie Edrada-Ebel
    Ronald J. Quinn
    Nature Reviews Drug Discovery, 2015, 14 : 111 - 129
  • [23] MUMPS MENINGITIS AND MEASLES, MUMPS, AND RUBELLA VACCINE
    COLVILLE, A
    PUGH, S
    LANCET, 1992, 340 (8822): : 786 - 786
  • [24] MUMPS VIRUSES AND MUMPS, MEASLES, AND RUBELLA VACCINE
    FORSEY, T
    MINOR, PD
    BRITISH MEDICAL JOURNAL, 1989, 299 (6711): : 1340 - 1340
  • [25] The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development
    Zahmanova, Gergana
    Takova, Katerina
    Tonova, Valeria
    Koynarski, Tsvetoslav
    Lukov, Laura L.
    Minkov, Ivan
    Pishmisheva, Maria
    Kotsev, Stanislav
    Tsachev, Ilia
    Baymakova, Magdalena
    Andonov, Anton P.
    VIRUSES-BASEL, 2023, 15 (07):
  • [26] Waning population immunity to measles in Taiwan
    Chen, Chih-Jung
    Lee, Ping-Ing
    Hsieh, Yu-Chia
    Chen, Po-Yen
    Ho, Yu-Huai
    Chang, Chee-Jen
    Liu, Ding-Ping
    Chang, Feng-Yee
    Chiu, Cheng-Hsun
    Huang, Yhu-Chering
    Lee, Chin-Yun
    Lin, Tzou-Yien
    VACCINE, 2012, 30 (47) : 6721 - 6727
  • [27] MEASLES, MUMPS AND RUBELLA VACCINE
    MILLER, E
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1988, 40 (04): : 247 - &
  • [28] MEASLES MUMPS RUBELLA VACCINE
    不详
    LANCET, 1988, 2 (8606): : 347 - 347
  • [29] A Re-emergence of Ogres
    Schumacher, Matt
    EXTRAPOLATION, 2012, 53 (03) : 385 - 388
  • [30] The re-emergence of bluetongue
    Baylis, M
    VETERINARY JOURNAL, 2002, 164 (01): : 5 - 6